Log in | Register

Home
All Journals
Expert Opinion on Biological Therapy
List of Issues
Volume 15, Issue 12

Expert Opinion on Biological Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Biological Therapy, Volume 15, Issue 12 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 15, Issue 12 (2015)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Volume 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Redirected T cells in cancer therapy

Dario Sangiolo

Pages: 1667-1670

Published online: 29 Oct 2015

AbstractforRedirected T cells in cancer therapy | Full Text | References | PDF (181.5 KB)

1734 Views
1 CrossRef citations
0Altmetric

Free Access

Key Paper Evaluation

Is there enough evidence with evolocumab and alirocumab (antibodies to proprotein convertase substilisin-kexin type, PCSK9) on cardiovascular outcomes to use them widely?

Evaluation of Sabatine MS, Giugliano RP, Wiviott SD et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med 2015;372:1500-1509, and Robinson JG, Farnier M, Krempf M et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med 2015;372:1488-99.

Sheila Anne Doggrell (Senior Lecturer in Pharmacology) & Kaileen Anne Lynch

Pages: 1671-1675

Published online: 28 Sep 2015

AbstractforIs there enough evidence with evolocumab and alirocumab (antibodies to proprotein convertase substilisin-kexin type, PCSK9) on cardiovascular outcomes to use them widely? | Full Text | References | PDF (409.5 KB)

1108 Views
5 CrossRef citations
0Altmetric

Original Research

Article

Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data

Elena Nikiphorou, Hannu Kautiainen, Pekka Hannonen, Juha Asikainen, Arto Kokko, Tuomas Rannio & Tuulikki Sokka

Pages: 1677-1683

Published online: 07 Nov 2015

AbstractforClinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data | Full Text | References | PDF (233.3 KB)

1681 Views
99 CrossRef citations
0Altmetric

Reviews

Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials

Irini Chatziralli MD PhD FEBO, Luke Nicholson, Sobha Sivaprasad & Philip Hykin

Pages: 1685-1697

Published online: 11 Sep 2015

AbstractforIntravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials | Full Text | References | PDF (609.9 KB)

454 Views
10 CrossRef citations
0Altmetric

Prospect and progress of gene therapy in treating atherosclerosis

Annukka M Kivelä PhD, Jenni Huusko PhD & Seppo Ylä-Herttuala MD PhD FESC

Pages: 1699-1712

Published online: 31 Aug 2015

AbstractforProspect and progress of gene therapy in treating atherosclerosis | Full Text | References | PDF (829.6 KB)

471 Views
9 CrossRef citations
0Altmetric

Treatment of severe asthma: entering the era of targeted therapy

Amanda R van Buul & Christian Taube

Pages: 1713-1725

Published online: 31 Aug 2015

AbstractforTreatment of severe asthma: entering the era of targeted therapy | Full Text | References | PDF (801.1 KB)

798 Views
9 CrossRef citations
0Altmetric

Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis

Alessia Alunno MD, Francesco Carubbi MD PhD, Giacomo Cafaro MD, Giacomo Pucci MD, Francesca Battista MD, Elena Bartoloni MD, Roberto Giacomelli MD PhD, Giuseppe Schillaci MD & Roberto Gerli MD

Pages: 1727-1737

Published online: 07 Sep 2015

AbstractforTargeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis | Full Text | References | PDF (793.5 KB)

1195 Views
27 CrossRef citations
0Altmetric

Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy

Maryam Esfahani, Fatemeh Karimi, Saeid Afshar, Somayeh niknazar, Sareh Sohrabi & Rezvan Najafi

Pages: 1739-1755

Published online: 28 Aug 2015

AbstractforProlyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy | Full Text | References | PDF (854.4 KB)

285 Views
18 CrossRef citations
0Altmetric

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Volker Schirrmacher

Pages: 1757-1771

Published online: 05 Oct 2015

AbstractforOncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance | Full Text | References | PDF (717.9 KB)

795 Views
39 CrossRef citations
0Altmetric

Update on Mucin-1 immunotherapy in cancer: a clinical perspective

Gareth Rivalland (Medical Oncology Fellow) BHB MBChB FRACP, Bruce Loveland (Burnet Institute Principal Fellow) PhD & Paul Mitchell (Senior Medical Oncologist) BHB MBChB MD FRACP GAICD

Pages: 1773-1787

Published online: 09 Oct 2015

AbstractforUpdate on Mucin-1 immunotherapy in cancer: a clinical perspective | Full Text | References | PDF (723.1 KB)

690 Views
35 CrossRef citations
0Altmetric

Drug Evaluations

Article

Nivolumab for treating non-small cell lung cancer

Nicolas Guibert & Julien Mazières

Pages: 1789-1797

Published online: 16 Nov 2015

AbstractforNivolumab for treating non-small cell lung cancer | Full Text | References | PDF (651.7 KB)

1106 Views
23 CrossRef citations
0Altmetric

Article

Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors

Matteo Lambertini, Arlindo R Ferreira, Lucia Del Mastro, Romano Danesi & Paolo Pronzato

Pages: 1799-1817

Published online: 21 Oct 2015

AbstractforPegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors | Full Text | References | PDF (715.7 KB)

679 Views
13 CrossRef citations
0Altmetric

Tremelimumab for the treatment of malignant mesothelioma

Alice Guazzelli, Michelle Hussain, Marija Krstic-Demonacos & Luciano Mutti

Pages: 1819-1829

Published online: 14 Dec 2015

AbstractforTremelimumab for the treatment of malignant mesothelioma | Full Text | References | PDF (400.6 KB)

451 Views
20 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Biologic therapy for chronic spontaneous urticaria in pediatrics and adolescents: current landscape, challenges, and future perspectives

Katharina Marlies Duda et al.

Review Article | Published online: 17 May 2024

Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature

Emiliano Barbieri et al.

Review Article | Published online: 17 May 2024

Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosis

Yan Jiang et al.

Article | Published online: 16 May 2024

Meta-analysis of response rates to first-line salvage treatment after CAR-T therapy failure in large B-cell lymphoma patients

Jaromir Tomasik et al.

Review Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Biological Therapy (Vol.15, Iss.12, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?